Vincent Vellucci

1.2k total citations
21 papers, 968 citations indexed

About

Vincent Vellucci is a scholar working on Molecular Biology, Infectious Diseases and Hepatology. According to data from OpenAlex, Vincent Vellucci has authored 21 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in Vincent Vellucci's work include TGF-β signaling in diseases (6 papers), Hepatitis C virus research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Vincent Vellucci is often cited by papers focused on TGF-β signaling in diseases (6 papers), Hepatitis C virus research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Vincent Vellucci collaborates with scholars based in United States, Japan and Australia. Vincent Vellucci's co-authors include Michael Reiß, Laure Garrigue‐Antar, Joan Gesmonde, Scott Antonia, Rebecca G. Wells, E. Scott Swenson, Marianna Gaça, Chenghai Liu, Anton K. Beck and F. Joseph Germino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Vincent Vellucci

21 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Vellucci United States 15 591 280 153 148 148 21 968
Rong‐Yaun Shyu Taiwan 20 491 0.8× 173 0.6× 110 0.7× 171 1.2× 143 1.0× 40 1.1k
Yiu‐Loon Chui Hong Kong 19 580 1.0× 310 1.1× 93 0.6× 95 0.6× 34 0.2× 45 1.2k
Kazuhiro Hayashida Japan 17 367 0.6× 336 1.2× 37 0.2× 196 1.3× 178 1.2× 44 1.4k
Ning Go United States 10 376 0.6× 278 1.0× 76 0.5× 163 1.1× 48 0.3× 18 1.5k
Solange Romagnoli Italy 18 239 0.4× 293 1.0× 69 0.5× 240 1.6× 63 0.4× 35 1.0k
Ken Sato Japan 14 496 0.8× 197 0.7× 116 0.8× 131 0.9× 23 0.2× 43 1.0k
Nae Choon Yoo South Korea 17 320 0.5× 415 1.5× 56 0.4× 81 0.5× 76 0.5× 55 976
Alexander Pedroza‐González Mexico 15 274 0.5× 854 3.0× 72 0.5× 142 1.0× 139 0.9× 26 1.6k
Ligia Craciun Belgium 20 457 0.8× 865 3.1× 74 0.5× 133 0.9× 90 0.6× 49 2.0k
Pascale F Macgregor Canada 15 480 0.8× 137 0.5× 39 0.3× 186 1.3× 36 0.2× 16 866

Countries citing papers authored by Vincent Vellucci

Since Specialization
Citations

This map shows the geographic impact of Vincent Vellucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Vellucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Vellucci more than expected).

Fields of papers citing papers by Vincent Vellucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Vellucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Vellucci. The network helps show where Vincent Vellucci may publish in the future.

Co-authorship network of co-authors of Vincent Vellucci

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Vellucci. A scholar is included among the top collaborators of Vincent Vellucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Vellucci. Vincent Vellucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McPhee, Fiona, et al.. (2019). Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on theIn VitroPotency of Direct-Acting Antiviral Agents. Antimicrobial Agents and Chemotherapy. 63(4). 5 indexed citations
2.
3.
Zhou, Nannan, Zhonglin Han, Stephan Neumann, et al.. (2016). High Sustained Virologic Response Rates in Patients Infected with Genotype 2 with Baseline NS5A Polymorphisms Treated with Daclatasvir-Based Regimens. Journal of Hepatology. 64(2). S407–S407. 2 indexed citations
4.
Zhou, Nannan, et al.. (2016). Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens. Journal of Antimicrobial Chemotherapy. 71(12). 3495–3505. 13 indexed citations
5.
Liu, Geoffrey, et al.. (2009). Simvastatin Inhibits Candida albicans Biofilm In Vitro. Pediatric Research. 66(6). 600–604. 33 indexed citations
6.
Vellucci, Vincent, et al.. (2008). Superantigen‐Like Effects of aCandida albicansPolypeptide. The Journal of Infectious Diseases. 197(7). 981–989. 14 indexed citations
7.
Vellucci, Vincent, Scott E. Gygax, & Margaret K. Hostetter. (2006). Involvement of Candida albicans pyruvate dehydrogenase complex protein X (Pdx1) in filamentation. Fungal Genetics and Biology. 44(10). 979–990. 29 indexed citations
8.
Liu, Chenghai, Marianna Gaça, E. Scott Swenson, et al.. (2003). Smads 2 and 3 Are Differentially Activated by Transforming Growth Factor-β (TGF-β) in Quiescent and Activated Hepatic Stellate Cells. Journal of Biological Chemistry. 278(13). 11721–11728. 160 indexed citations
9.
Yan, Wei, et al.. (1998). Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.. PubMed. 58(9). 1986–92. 14 indexed citations
10.
Vellucci, Vincent & Michael Reiß. (1997). Cloning and Genomic Organization of the Human Transforming Growth Factor-β Type I Receptor Gene. Genomics. 46(2). 278–283. 26 indexed citations
11.
Vellucci, Vincent, et al.. (1997). Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.. PubMed. 8(4). 407–15. 24 indexed citations
12.
Garrigue‐Antar, Laure, et al.. (1996). Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.. PubMed. 75(2). 263–72. 49 indexed citations
13.
Vellucci, Vincent, F. Joseph Germino, & Michael Reiß. (1995). Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. Gene. 166(2). 213–220. 61 indexed citations
14.
Garrigue‐Antar, Laure, et al.. (1995). Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.. PubMed. 55(18). 3982–7. 184 indexed citations
15.
Vellucci, Vincent, et al.. (1993). Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.. PubMed. 53(4). 899–904. 61 indexed citations
16.
Muñoz-Antonia, Teresita, et al.. (1993). Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta.. PubMed. 4(12). 993–1004. 22 indexed citations
17.
Brash, Douglas E., et al.. (1992). Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.. PubMed. 4(8-9). 349–57. 77 indexed citations
18.
Watkins, Paul C., Roger L. Eddy, Anton K. Beck, et al.. (1987). DNA Sequence and Regional Assignment of the Human Follicle-Stimulating Hormone β-Subunit Gene to the Short Arm of Human Chromosome 11. DNA. 6(3). 205–212. 105 indexed citations
19.
Watkins, Paul C., Roger L. Eddy, Anton K. Beck, et al.. (1986). Regional assignment of the erythropoietin gene to human chromosome region 7pter→q22. Cytogenetic and Genome Research. 42(4). 214–218. 42 indexed citations
20.
Reddy, V.B., et al.. (1985). Expression of human choriogonadotropin in monkey cells using a single simian virus 40 vector.. Proceedings of the National Academy of Sciences. 82(11). 3644–3648. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rong‐Yaun Shyu Breakdown of academic impact, for papers by Yiu‐Loon Chui Breakdown of academic impact, for papers by Kazuhiro Hayashida Breakdown of academic impact, for papers by Ning Go Breakdown of academic impact, for papers by Solange Romagnoli Breakdown of academic impact, for papers by Ken Sato Breakdown of academic impact, for papers by Nae Choon Yoo Breakdown of academic impact, for papers by Alexander Pedroza‐González Breakdown of academic impact, for papers by Ligia Craciun Breakdown of academic impact, for papers by Pascale F Macgregor
Rankless by CCL
2026